Literature DB >> 10967447

Determination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomes.

K Shimada1, S Matsuo, Y Sadzuka, A Miyagishima, Y Nozawa, S Hirota, T Sonobe.   

Abstract

We describe a method for determining incorporated amounts of poly(ethylene glycol) (PEG)-derivatized lipids in liposomes for the physicochemical characterization of PEG-coated liposomes. This method is based on the spectrophotometric determination of complexes of polyethers with sodium ions after their extraction as picrates into 1,2-dichloroethane, developed by Favretto for measuring levels of polyoxyethylene alkylphenyl-ether non-ionic surfactants in waste water. The same assay was applied to the estimation of PEG-derivatized lipids in liposomes and percent incorporation of PEG-derivatized lipids into liposomes was successfully determined. To prevent the interference from liposomal lipids other than PEG-derivatized lipids in this assay, liposomal samples were diluted at least to a concentration of less than 0.2 mM. The percent incorporation of PEG-lipids varied, depending on the molecular weight of PEG and anchor acyl chain length in PEG-lipids and it was suggested that the percent incorporation of PEG-lipids into liposomes would be a good parameter of quality control of PEG-liposomes in manufacturing facility and the picrate method used in the present study allows for the determination of this parameter without the need for hazardous radioisotopes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10967447     DOI: 10.1016/s0378-5173(00)00466-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  The effect of chain length on protein solubilization in polymer-based vesicles (polymersomes).

Authors:  Veena Pata; Nily Dan
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

2.  Chemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response.

Authors:  Anuradha Soundararajan; Ande Bao; William T Phillips; Linda M McManus; Beth A Goins
Journal:  Cancer Biother Radiopharm       Date:  2011-08-11       Impact factor: 3.099

3.  Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.

Authors:  Erez Koren; Anjali Apte; Ankur Jani; Vladimir P Torchilin
Journal:  J Control Release       Date:  2011-12-13       Impact factor: 9.776

4.  Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles.

Authors:  Jie Zheng; Yu Wan; Abdelbary Elhissi; Zhirong Zhang; Xun Sun
Journal:  Pharm Res       Date:  2014-03-05       Impact factor: 4.200

5.  Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles.

Authors:  Yongxue Zhao; Long Wang; Mina Yan; Yanling Ma; Guangxi Zang; Zhennan She; Yihui Deng
Journal:  Int J Nanomedicine       Date:  2012-06-12

6.  Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery.

Authors:  Dawei Gao; Shengnan Tang; Qi Tong
Journal:  Int J Nanomedicine       Date:  2012-07-06

Review 7.  Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Authors:  Hongkee Sah; Laura A Thoma; Hari R Desu; Edel Sah; George C Wood
Journal:  Int J Nanomedicine       Date:  2013-02-21

8.  Gd(III)-DOTA-modified sonosensitive liposomes for ultrasound-triggered release and MR imaging.

Authors:  Suk Hyun Jung; Kyunga Na; Seul A Lee; Sun Hang Cho; Hasoo Seong; Byung Cheol Shin
Journal:  Nanoscale Res Lett       Date:  2012-08-17       Impact factor: 4.703

9.  Surface engineering of liposomes for stealth behavior.

Authors:  Okhil K Nag; Vibhudutta Awasthi
Journal:  Pharmaceutics       Date:  2013-10-25       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.